Molecular formula: | C30H42N8O3 |
Average mass: | 562.719 |
Monoisotopic mass: | 562.337987 |
ChemSpider ID: | 44210447 |
1 of 1 defined stereocentres
1448232-80-1
[RN]2-Pyrazinecarboxamide, 6-ethyl-3-[[4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[[(3R)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]oxy]-
[ACD/Index Name]5-{[(3R)-1-Acryloyl-3-pyrrolidinyl]oxy}-6-ethyl-3-({4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl}amino)-2-pyrazincarboxamid
[German]
[ACD/IUPAC Name]5-{[(3R)-1-Acryloyl-3-pyrrolidinyl]oxy}-6-ethyl-3-({4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl}amino)-2-pyrazinecarboxamide
[ACD/IUPAC Name]5-{[(3R)-1-Acryloyl-3-pyrrolidinyl]oxy}-6-éthyl-3-({4-[4-(4-méthyl-1-pipérazinyl)-1-pipéridinyl]phényl}amino)-2-pyrazinecarboxamide
[French]
[ACD/IUPAC Name]6-ethyl-3-({4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)-5-{[(3R)-1-(1-oxoprop-2-en-1-yl)pyrrolidin-3-yl]oxy}pyrazine-2-carboxamide
6-Ethyl-3-{4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino}-5-{[(3R)-1-(prop-2-enoyl)pyrrolidin-3-yl]oxy}pyrazine-2-carboxamide
naquotinib
[INN] [USAN]naquotinib
[French]
[INN]naquotinib
[Spanish]
[INN]naquotinibum
[Latin]
[INN]наквотиниб
[Russian]
[INN]ناكوتينيب
[Arabic]
[INN]那考替尼
[Chinese]
[INN]1448232-80-1 (free base)
4-(3,4-dihydroquinolin-1(2H)-yl)-1,3,5-triazin-2-amine
6-ETHYL-3-({4-[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL]PHENYL}AMINO)-5-{[(3R)-1-(PROP-2-ENOYL)PYRROLIDIN-3-YL]OXY}PYRAZINE-2-CARBOXAMIDE
6-ethyl-3-[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxypyrazine-2-carboxamide
6-ethyl-3-[[4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[[(3R)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]oxy]-2-pyrazinecarboxamide
Epidermal growth factor receptor
MFCD30496701
[MDL number]Naquotinib free base
naquotinibum
US9085540, 54
наквотиниб
ناكوتينيب
那考替尼